Matribhumi Samachar English
Toronto, Ontario–(Newsfile Corp. – March 24, 2025) – Optimind Pharma Corp. (CSE: OMND) (the “Optimind” or the “Company”) announces that it has entered into a non-binding letter of intent dated March 18, 2025, (the “LOI”) to acquire all of the issued and outstanding shares (the “Transaction”) of Monjin Interviews Private …
Read More »